Search
Liminatus Pharma Ord Shs Class A
LIMNAdd to Watchlist
0.184USD
+0.001+0.27%
Market hours （ET）Quotes delayed by 15 min
4.99MMarket Cap
LossP/E TTM
More Details of Company
Liminatus Pharma Ord Shs Class A Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Liminatus Pharma Ord Shs Class A
Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
16.67K
--
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Sang-jin Daniel Lee
Mr. Sang-jin Daniel Lee
Head - Research & Development
Head - Research & Development
--
--
Dr. Byong C. Yoo, Ph.D.
Dr. Byong C. Yoo, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Mr. Beom K. Choi
Mr. Beom K. Choi
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Philip Lemons
Mr. Philip Lemons
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Nicholas Fernandez
Mr. Nicholas Fernandez
Independent Director
Independent Director
16.67K
--
Mr. Rohit Nanani
Mr. Rohit Nanani
Director
Director
--
--
Mr. Chris Kim
Mr. Chris Kim
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Eun Sook Lee, M.D., Ph.D.
Dr. Eun Sook Lee, M.D., Ph.D.
Independent Director
Independent Director
--
--
Ms. Ji Yeon Baek
Ms. Ji Yeon Baek
Independent Director
Independent Director
--
--
Mr. Scott Dam
Mr. Scott Dam
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Valetudo Therapeutics LLC
13.75%
Feelux Co Ltd
5.94%
Iris Acquisition Holdings LLC
5.64%
Ewon Comfortech Co Ltd
3.34%
Red Peony Association 1st
3.28%
Other
68.06%
Shareholders
Shareholders
Proportion
Valetudo Therapeutics LLC
13.75%
Feelux Co Ltd
5.94%
Iris Acquisition Holdings LLC
5.64%
Ewon Comfortech Co Ltd
3.34%
Red Peony Association 1st
3.28%
Other
68.06%
Shareholder Types
Shareholders
Proportion
Corporation
38.49%
Investment Advisor
0.31%
Hedge Fund
0.28%
Investment Advisor/Hedge Fund
0.19%
Individual Investor
0.04%
Other
60.69%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
13
261.92K
0.76%
--
2026Q1
23
425.78K
0.95%
+6.79K
2025Q4
19
240.79K
0.89%
-191.91K
2025Q3
21
261.92K
0.97%
-218.50K
2025Q2
19
204.70K
0.79%
-924.41K
2025Q1
11
--
0.00%
-1.16M
2024Q4
23
--
0.00%
-6.45M
2024Q3
70
16.83K
0.23%
-24.70M
2024Q2
75
146.55K
2.04%
-25.63M
2024Q1
79
231.31K
3.22%
-26.92M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Valetudo Therapeutics LLC
6.17M
15.68%
--
--
Feb 13, 2026
Feelux Co Ltd
2.67M
6.78%
-1.33M
-33.33%
Feb 13, 2026
Iris Acquisition Holdings LLC
2.53M
6.43%
-4.37M
-63.33%
Feb 13, 2026
Ewon Comfortech Co Ltd
1.50M
3.81%
--
--
Feb 13, 2026
Red Peony Association 1st
1.47M
3.74%
--
--
Feb 13, 2026
Nongae Apple Association 1st
1.47M
3.74%
--
--
Feb 13, 2026
Arrow MultiAsset Fund SPC-SP4
1.47M
3.73%
+1.47M
--
Feb 13, 2026
Citadel Advisors LLC
70.93K
0.18%
+70.93K
--
Dec 31, 2025
Geode Capital Management, L.L.C.
65.05K
0.17%
+1.32K
+2.07%
Dec 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
